New GPU engine in the on-device AI framework delivers comprehensive GPU and NPU support across Android, iOS, macOS, Windows, Linux, and web platforms. LiteRT, Google’s “modern” on-device inference ...

Advanced Micro Devices is rated a hold due to a lack of a competitive MOAT and lagging AI accelerator performance versus NVDA. AMD's revenue and earnings are expected to grow 20–30% YoY, but market ...

The global memory industry is confronting a growing capacity crunch, one that is increasingly rippling upstream to a shortage of glass fiber cloth, an obscure but indispensable material in advanced ...

EMERYVILLE, Calif.--(BUSINESS WIRE)--Eureka Therapeutics, Inc., a clinical-stage biotechnology company advancing next-generation T-cell therapies for cancer, today announced that the U.S. Food and ...

Nvidia got the green light from President Donald Trump to sell its more advanced H200 AI chip to China. But there are questions over whether Beijing will want to buy them given its drive for ...

U.S. President Donald Trump announced Nvidia will be able to sell a more advanced H200 chip to China. Several analysts were quick to point out this move would help boost China's AI capabilities.

Nvidia told investors back in August that its October-quarter revenue would hit $54 billion — a jaw-dropping 54% jump from last year. This isn't just acceleration; it's escape velocity. AMD, by ...

The president told reporters in the Oval Office on Monday that he planned to sell the advanced fighter jets to Riyadh. By Karoun Demirjian Reporting from Washington President Trump said on Monday that ...

Step-by-step guide to mastering Meta Ray-Ban Smart Glasses setup and usage for a seamless and hands-free connected experience. Ray-Ban - Official site Meta Ray-Ban Smart Glasses blend style and ...

WASHINGTON, Nov 4 (Reuters) - The Trump administration is not planning to allow Nvidia (NVDA.O), opens new tab to sell its most advanced AI chip, known as the Blackwell, to China right now, the White ...

Patients with previously untreated, locally advanced, unresectable or metastatic triple-negative breast cancer who are not candidates for inhibitors of programmed cell death protein 1 (PD-1) or ...